What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His scientific interests lie mostly in Internal medicine, Transplantation, Surgery, Immunology and Gastroenterology.
As part of his studies on Internal medicine, Daniel J. Weisdorf often connects relevant subjects like Oncology.
His studies in Transplantation integrate themes in fields like Transplantation Conditioning, Leukemia and Total body irradiation.
Daniel J. Weisdorf works mostly in the field of Surgery, limiting it down to topics relating to Incidence and, in certain cases, Allogeneic transplantation.
His Immunology study incorporates themes from Stem cell and KIR Ligand.
His work deals with themes such as Mucositis, Methotrexate, Umbilical cord, Umbilical Cord Blood Transplantation and Blood transfusion, which intersect with Gastroenterology.
His most cited work include:
- 1994 Consensus Conference on Acute GVHD Grading. (3785 citations)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report (3120 citations)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease (2220 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Transplantation, Surgery, Gastroenterology and Hematopoietic stem cell transplantation.
His research ties Oncology and Internal medicine together.
His Transplantation research incorporates elements of Hematopoietic cell, Umbilical cord, Leukemia, Immunology and Total body irradiation.
His study brings together the fields of Confidence interval and Surgery.
His Gastroenterology research is multidisciplinary, incorporating elements of Incidence, Umbilical Cord Blood Transplantation, Neutrophil Engraftment, Fludarabine and Acute leukemia.
His Hematopoietic stem cell transplantation research integrates issues from Young adult, Relative risk, Hematology, Retrospective cohort study and Transplantation Conditioning.
He most often published in these fields:
- Internal medicine (67.82%)
- Transplantation (62.14%)
- Surgery (32.66%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (67.82%)
- Transplantation (62.14%)
- Oncology (21.97%)
In recent papers he was focusing on the following fields of study:
Daniel J. Weisdorf mainly focuses on Internal medicine, Transplantation, Oncology, Gastroenterology and Hematopoietic stem cell transplantation.
His Graft-versus-host disease, Disease, Leukemia, Myeloid leukemia and Hazard ratio study are his primary interests in Internal medicine.
His Transplantation research focuses on Hematopoietic cell and how it connects with Marrow transplantation.
His studies in Oncology integrate themes in fields like Clinical trial, Complete remission, Chemotherapy, Bone transplantation and Allogeneic transplantation.
His Gastroenterology research includes elements of Total body irradiation, Cyclophosphamide, Fludarabine and Acute leukemia.
His study in Hematopoietic stem cell transplantation is interdisciplinary in nature, drawing from both Transplantation Conditioning, Retrospective cohort study and Intensive care medicine.
Between 2017 and 2021, his most popular works were:
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation (141 citations)
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (99 citations)
- Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203) (59 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Daniel J. Weisdorf mostly deals with Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Gastroenterology and Graft-versus-host disease.
His Transplantation study combines topics in areas such as Hematopoietic cell, Cyclophosphamide, Retrospective cohort study, Myeloid leukemia and Leukemia.
His research links Oncology with Internal medicine.
His research in Hematopoietic stem cell transplantation intersects with topics in MEDLINE, Young adult, Umbilical cord, Intensive care medicine and Transplantation Conditioning.
His studies deal with areas such as Odds ratio, Lower risk, Methotrexate and Chronic myelogenous leukemia as well as Gastroenterology.
Daniel J. Weisdorf interconnects Cytokine, Cell transplantation, Multicenter trial, Survival analysis and Bone marrow in the investigation of issues within Graft-versus-host disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
